stopOverflowHandler
MONOCLONAL ANTIBODY TARGETING AURORA-A KINASE
Principal Investigator: C. PRIGENT
TECHNICAL DESCRIPTION

The present invention is a monoclonal antibody which targets the mammal aurora-A kinase (human and mouse). As the overexpression of aurora-A kinase has been observed in many tumors, it is very important to assess its expression.
Mice were injected with human recombinant aurora-A kinase and then killed. Spleen cells were extracted and fused with immortalized hamster cells to obtain a hybridome. A hybridome has been isolated that produces an antibody with a high affinity for the aurora-A kinase.


Pour lire la suite, merci de vous identifier ou de vous inscrire dans la zone de droite...
 
< Précédent   Suivant >
 
 

Identification






Direct Access
+33 1 40 51 00 90
08/04/13 : CNRS atteint la 5ème place du classement INPI de 2012

Le CNRS atteint la 5ème place du classement INPI des premiers organismes et entrerpises déposants en 2012 ...
Details ...



17/01/13 : Science to Market, Cologne, Germany 5th - 6th March, 2013

Science to Market - S2M - is the platform for European scientific research and biopharmaceutical industry ...
Details ...



04/02/13 : Une technologie valorisée par FIST SA dans la presse (Muller)  Lupus : des essais cliniques confirment l'efficacité du peptide P140/LupuzorTM Details ...



 
   
viagra 100mg